Patent · US Active

2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

US9675615B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignees

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR
The Board of Regents of the University of Texas System · US

Inventors

Daniel Gillet · Paris, FR
Julien Barbier · San Francisco, US
Robert A. Davey · San Antonio, US
Jean-Christophe Cintrat · Igny, FR
Romain Noel · Villeurbanne, FR

Key dates

Filing date	Oct 18, 2013
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Oct 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of 2,3-dihydroquinazolin-4(1H)-one cyclic derivatives of formula (I) for the treatment of infection with viruses entering cells by endocytosis, especially filovirus such as Ebolavirus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.